Notice of Results

RNS Number : 1522T
Omega Diagnostics Group PLC
02 July 2018
 

Omega Diagnostics Group PLC

("Omega" or "the Company")

 

Announcement of results

 

Omega (AIM: ODX), the medical diagnostics company, announces that it will release its results for the year ended 31 March 2018 on Monday 6 August 2018.

 

Further to the disposal of our infectious disease business (excluding VISITECT® CD4), which we announced on 28 June 2018, the extended timeline for releasing results will enable the Company to prioritise its stated objectives.

 

 

Contacts:

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

David Evans, Chairman

Colin King, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director




finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)


Camille Gochez (Corporate Broking)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Helen Cresswell

Mob: 07841 917 679

Paul McManus

Mob: 07980 541 893

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORDMGZVVLNGRZM
UK 100